Curis opens 11 CLL trial sites, stockholders approve reverse split

June 26, 2026 9:43 AM

Curis, Inc. (NASDAQ: CRIS) announced that eleven clinical sites are now open for patient enrollment in its Phase 2 TakeAim ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found